Bicara Therapeutics Common Stock Overview
Bicara Therapeutics Common Stock Target Price
Analysts' 12-month price predictions for BCAX.
Get informed when a big investor buys or sells
+ FollowShare Price
$29
Average Target Price
$32.33
11.5% upside
11.5% upside3 analysts in the last 4 months
High: $42 | Low: $18
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-12 | Morgan Stanley | $37 | 27.6% upside |  |
| 2026-05-12 | Goldman Sachs | $18 |  37.9% downside | |
| 2026-05-11 | Guggenheim | $42 | 44.8% upside | |
| 2026-02-11 | Goldman SachsRichard Law | $14 | 51.7% downside | |
| 2026-01-08 | BTIG | $28 | 3.4% downside | |
| 2025-12-17 | Mizuho SecuritiesJoseph Catanzaro | $18 | 37.9% downside | |
| 2025-08-22 | H.C. WainwrightRobert Burns | $40 | 37.9% upside | |
| 2025-05-23 | Wells FargoEva Fortea Verdejo | $8 | 72.4% downside | |
| 2025-03-27 | Stifel Nicolaus | $48 | 65.5% upside | |
| 2024-10-08 | Morgan StanleyJudah Frommer | $35 | 20.7% upside | |